Please wait
S-8 S-8 EX-FILING FEES 0001754068 Kalaris Therapeutics, Inc. N/A Fees to be Paid Fees to be Paid 0001754068 2026-03-13 2026-03-13 0001754068 1 2026-03-13 2026-03-13 0001754068 2 2026-03-13 2026-03-13 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Kalaris Therapeutics, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, $0.0001 par value per share Other 1,145,120 $ 9.12 $ 10,443,494.40 0.0001381 $ 1,442.25
2 Equity Common Stock, $0.0001 par value per share Other 53,161 $ 9.12 $ 484,828.32 0.0001381 $ 66.96

Total Offering Amounts:

$ 10,928,322.72

$ 1,509.21

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 1,509.21

Offering Note

1

(1) In accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. (2) Consists of 1,145,120 additional shares issuable under the 2020 Stock Option and Grant Plan. (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Registrant's Common Stock as reported on The Nasdaq Global Market on March 12, 2026.

2

(1) In accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. (3) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Registrant's Common Stock as reported on The Nasdaq Global Market on March 12, 2026. (4) Consists of 53,161 additional shares issuable under the 2020 Employee Stock Purchase Plan.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A